Nuveen
CLBT icon

Nuveen’s Cellebrite CLBT Stock Holding History

Nuveen’s Portfolio CLBT Stock Details CLBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.74M Buy
119,031
+34,230
+40% +$452K ﹤0.01% 2643
2026
Q1 		$1.17M Sell
84,801
-2,194,839
-96% -$33.1M ﹤0.01% 2511
2025
Q4 		$41.1M Buy
2,279,640
+130,013
+6% +$2.33M 0.01% 745
2025
Q3 		$39.8M Buy
2,149,627
+544,084
+34% +$8.55M 0.01% 738
2025
Q2 		$25.7M Buy
1,605,543
+831,930
+108% +$14.8M 0.01% 943
2025
Q1 		$15M Buy
773,613
+187,774
+32% +$3.95M ﹤0.01% 1306
2024
Q4 		$12.9M Buy
585,839
+162,886
+39% +$3.14M ﹤0.01% 1458
2024
Q3 		$7.12M Buy
422,953
+382,289
+940% +$5.67M ﹤0.01% 1811
2024
Q2 		$486K Hold
40,664
– – ﹤0.01% 3005
2024
Q1 		$451K Hold
40,664
– – ﹤0.01% 3007
2023
Q4 		$352K Buy
+40,664
New +$316K ﹤0.01% 3111

Other funds holding CLBT

TWCM
True Wind Capital Management San Francisco, California $226M AUM 2.79% 1-Year Est. Return
VC
Voss Capital Houston, Texas $2.15B AUM 33.46% 1-Year Est. Return
PP
Pertento Partners London, United Kingdom $1.86B AUM 53.86% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NTCM
Nine Ten Capital Management Chicago, Illinois $321M AUM 44.58% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

Nuveen's CLBT Position: Q2 2026 in Review

Nuveen increased its Cellebrite (CLBT) stake by 40% in Q2 2026, buying an estimated $452K and bringing the position to 119,031 shares worth $1.74M. The position accounts for ﹤0.01% of the portfolio, ranked #2643.

Nuveen first reported a position in CLBT in Q4 2023 and has held it in 11 quarters since. The position peaked at $41.1M in Q4 2025. 201 funds tracked by Wall St. Rank hold CLBT as of Q2 2026.

  • Nuveen held 119,031 shares of Cellebrite worth $1.74M as of Q2 2026.
  • Nuveen bought 34,230 Cellebrite shares in Q2 2026, an estimated $452K.
  • Cellebrite made up ﹤0.01% of Nuveen's portfolio in Q2 2026, its #2643 holding.
  • Nuveen first reported a position in Cellebrite in Q4 2023 and has held it in 11 quarters since.
  • Nuveen's Cellebrite position peaked at $41.1M in Q4 2025.
  • 201 funds tracked by Wall St. Rank held Cellebrite as of Q2 2026.

Based on Nuveen's 13F filing for Q2 2026, filed 11 Aug 2026.